COMPANIESAPOGEE MEDICAL GROUP, WAUKESHA, SC
✓ Verified H1B Sponsor

APOGEE MEDICAL GROUP, WAUKESHA, SC

Dallas, TXEIN 830723560
TRUST SCORE
92.9
High Trust
13
FY2024 H1B Approvals
13
All-time Approvals
92.9
Trust Score / 100

TOP SPONSORED JOB CATEGORIES

Hospitalists

RECENT H1B FILINGS

JOB TITLELOCATIONWAGEDATE
HospitalistsDallas, TX$336,536Sep 2025
HospitalistsDallas, TX$153.75Sep 2025
HospitalistsDallas, TX$153.75Jul 2025
HospitalistsDallas, TX$391,462Jul 2025
HospitalistsDallas, TX$336,536Jun 2025
HospitalistsDallas, TX$153.75Jun 2025
HospitalistsDallas, TX$391,462Jun 2025
HospitalistsDallas, TX$153.75Jun 2025
HospitalistsDallas, TX$153.75Jun 2025
HospitalistsDallas, TX$391,462Jun 2025
HospitalistsDallas, TX$445,388Feb 2025
HospitalistsDallas, TX$203.37Feb 2025
HospitalistsDallas, TX$336,536Feb 2025
HospitalistsDallas, TX$203.37Feb 2025
HospitalistsDallas, TX$445,388Feb 2025
HospitalistsDallas, TX$336,536Feb 2025

SHOWING 50 MOST RECENT · SOURCE: DOL LCA PUBLIC DATA FY2024 · EIN 830723560

FREQUENTLY ASKED QUESTIONS

Does APOGEE MEDICAL GROUP, WAUKESHA, SC sponsor H1B visas?

Yes. APOGEE MEDICAL GROUP, WAUKESHA, SC has an active H1B sponsorship history with 13 total approved LCA filings on record, including 13 approvals in FY2024. Data sourced from US Department of Labor public disclosure files.

How many H1B visas has APOGEE MEDICAL GROUP, WAUKESHA, SC sponsored?

According to DOL LCA data, APOGEE MEDICAL GROUP, WAUKESHA, SC has 13 all-time H1B approvals and 13 approvals in fiscal year 2024.

What types of roles does APOGEE MEDICAL GROUP, WAUKESHA, SC sponsor H1B for?

APOGEE MEDICAL GROUP, WAUKESHA, SC most commonly sponsors H1B visas for: Hospitalists. This is based on their DOL Labor Condition Application filing history.

Is APOGEE MEDICAL GROUP, WAUKESHA, SC a reliable H1B sponsor?

APOGEE MEDICAL GROUP, WAUKESHA, SC has a Trust Score of 92.9/100 on KEEL, calculated from total approval volume, recency of filings, and approval consistency based on DOL LCA data.

DATA SOURCE: US DEPT. OF LABOR · LCA PUBLIC DISCLOSURE FY2023–FY2024